NCT03553095

Brief Summary

This study will evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Jul 2018Dec 2026

First Submitted

Initial submission to the registry

May 29, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 12, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

July 12, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Expected
Last Updated

December 12, 2025

Status Verified

December 1, 2025

Enrollment Period

1.5 years

First QC Date

May 29, 2018

Last Update Submit

December 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gingival crevicular fluid (GCF)

    Measuring oral inflammatory markers in Gingival crevicular fluid (GCF) in patient with chronic periodontitis.

    baseline to 1 week

Secondary Outcomes (1)

  • Plaque

    baseline to 1 week

Other Outcomes (3)

  • Soft tissue

    baseline to 1 week

  • Blood Serum

    baseline to 1 week

  • Patient Health Questionnaire 8 (PHQ8)

    baseline to 1 week

Study Arms (3)

Chronic Periodontitis and Depression Medications

ACTIVE COMPARATOR

Patients with clinically diagnosed depression taking (SSRIs, NDRIs, SNRIs, tricyclic antidepressants) and with chronic periodontitis

Procedure: Periodontal Surgery

Chronic Periodontitis without Depression Medications

ACTIVE COMPARATOR

Patients with clinically diagnosed depression not taking any antidepressants (SSRIs NDRIs, SNRIs and Tricyclic antidepressants) and with chronic periodontitis

Procedure: Periodontal Surgery

Chronic Periodontitis

ACTIVE COMPARATOR

Patients without depression, not taking any antidepressants and with chronic periodontitis

Procedure: Periodontal Surgery

Interventions

Samples will be collected from patient in need of periodontal therapy (surgical procedures i.e. gum surgery, tooth extraction and or dental implant surgery). As standard during this procedures remnant tissue is otherwise discarded.

Chronic PeriodontitisChronic Periodontitis and Depression MedicationsChronic Periodontitis without Depression Medications

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Must be a patient of the UAB Dental School
  • Able to read and understand informed consent document
  • Good general health as evidenced by medical history
  • Minimum of 18 teeth, excluding third molars
  • Having moderate to severe periodontal disease according to AAP definition (teeth ≥5 mm PD and ≥3 mm CAL)
  • Having \>30 percent bleeding sites upon probing
  • Patients taking depression medication with chronic periodontitis
  • Patients without depression with chronic periodontitis
  • Patients who have not had a dental cleaning in the past 3 months prior to procedure
  • Patients scheduled for surgical procedures (i.e. gum surgery, tooth extraction, or dental implants)

You may not qualify if:

  • Non-English speaking
  • Less than 18 years old
  • Smokers/tobacco users (\>10 cigarettes/day)
  • Any dental condition that requires immediate treatment, such as emergency care
  • Chronic use (≥3 times/week) of anti-inflammatory medications (e.g., non-steroidal anti-inflammatory drugs, steroids). Low-dose aspirin (less than 325 mg daily)
  • Immunocompromised subjects
  • Any medical history or any concomitant medication that might affect the assessment of the study treatment or periodontal tissues, such as uncontrolled diabetes, nifedipine, phenytoin (Dilantin), subjects with arthritis and morbidly obese (BMI ≥ 40)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unversity of Alabama at Birmingham, School of Dentistry

Birmingham, Alabama, 35294-0007, United States

Location

MeSH Terms

Conditions

Chronic PeriodontitisDepression

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 29, 2018

First Posted

June 12, 2018

Study Start

July 12, 2018

Primary Completion

December 30, 2019

Study Completion (Estimated)

December 30, 2026

Last Updated

December 12, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations